Ellen Rohde

2.6k citations
25 papers · 2.1k · 4 hit papers · h-index 15

Impact in

Papers in

    • CRISPR and Genetic Engineering 6
    • RNA regulation and disease 2
    • Drug Transport and Resistance Mechanisms 4

Ellen Rohde

25 papers receiving 2.0k citations

Ellen Rohde's Hit Papers

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy 2023 · 127 citations
1270+2+5Years since publication200400600

Peers

Ellen Rohde
Comparison fields: 5 of 99
  • Business and International Management 85
  • Molecular Biology 1.5k
  • Aging 28
  • Genetics 378
  • Cardiology and Cardiovascular Medicine 176
Replace Meixin Liu with:
Meixin Liu China
Katarzyna Duda Poland
Robert L Eil United States
Anyong Xie United States
Suman Kumar Vodnala United States
Mei Zhao China
Dimas Echeverria United States
Yichao Lu China
David C. Clever United States
Bastiaan Evers Netherlands
Ellen Rohde relative to Meixin Liu China Meixin Liu's profile →
Citations per field
00.5×2×4×6×7.5×
Meixin Liu · 1×
Citations per year

Countries citing papers authored by Ellen Rohde

Since Specialization
Citations

This map shows the geographic impact of Ellen Rohde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Rohde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Rohde more than expected).

Fields of papers citing papers by Ellen Rohde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Rohde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Rohde. The network helps show where Ellen Rohde may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Rohde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Rohde Line = papers co-authored together Ellen Rohde links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Hit paper breakdown →
2018733
2
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Hit paper breakdown →
2021610
3
Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models
Hit paper breakdown →
2022185
4
GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy
Hit paper breakdown →
2023127
5 201170
6 201660
7 201858
8 199842
9 199336
10 201227
11 201123
12 201819
13 199817
14 201217
15 201116
16 201513
17 202311
18 202310
19 20109
20 20199

About Ellen Rohde

Ellen Rohde is a scholar working on Molecular Biology, Oncology, Immunology, Physiology and Rheumatology, having authored 25 papers that have together received 2.1k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Alzheimer's disease research and treatments (3 papers), Mass Spectrometry Techniques and Applications (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Computational Drug Discovery Methods (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Business and International Management (85 citations), Molecular Biology (1.5k citations), Aging (28 citations), Genetics (378 citations) and Cardiology and Cardiovascular Medicine (176 citations). Ellen Rohde has collaborated with scholars based in United States, Germany and Ireland. Frequent co-authors include Sekar Kathiresan, Andrew M. Bellinger, Amit V. Khera, Anne Marie Mazzola, Scott B. Vafai, Colin Platt, Richard G. Lee, Maurine C. Braun, Stephen Naylor and Douglas H. Johnson. Their work appears in journals such as Atherosclerosis, Bioorganic & Medicinal Chemistry Letters, ACS Central Science, Cancer Research and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact